Ann: Long COVID-19 strategic collaboration with US Experts, page-180

The way I see it:

1. From Taylor Collison Research Report (05-05-2022) and refer back to ASX announcement dated 14-12-2021 as well..
Preparations for the Phase IIb/III DMD trial on track -- Submission of clinical trial applications in the 9 participating countries in the Phase IIb/III European trial of ATL1102 will commence this month (MAY 2022);patient recruitment will commence once trial approvals are received.

2. Investor Presentation May 2022

• Site evaluations completed. Site selection close to finalization for sites (>30) in 9 countries
• Clinical trial agreements being executed with all trial sites and submission of the clinical trial application to be made to each of the national regulatory authorities
• Trial approvals expected to come through on a rolling basis depending on ethics and reg approval requirements of the individual authorities

and the Upcoming Key Activities;



So..... RELAX!!! and BE PATIENT!.....